News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
Presentation TCT 2024 TCT 706: One-Year Pooled Outcomes of Transcatheter Arterialization of the Deep Veins From the PROMISE I, II, and UK Studies Presenter: Mehdi Shishehbor October 30, 2024
Presentation TCT 2024 BTK and BTA: How is Promise II and DVA Making an impact? Presenter: Anahita Dua October 28, 2024
Presentation TCT 2024 One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients Presenter: Richard Powell October 28, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2024 Shelley Wood May 31, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
News Conference News ISET 2024 How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy Caitlin E. Cox January 24, 2024